Correlation Between Dianthus Therapeutics and GRAIL, LLC

Can any of the company-specific risk be diversified away by investing in both Dianthus Therapeutics and GRAIL, LLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dianthus Therapeutics and GRAIL, LLC into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Dianthus Therapeutics and GRAIL, LLC, you can compare the effects of market volatilities on Dianthus Therapeutics and GRAIL, LLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dianthus Therapeutics with a short position of GRAIL, LLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dianthus Therapeutics and GRAIL, LLC.

Diversification Opportunities for Dianthus Therapeutics and GRAIL, LLC

-0.06

Correlation Coefficient

Dianthus Therapeutics  GRAIL, LLC

Good diversification

The 3 months correlation between Dianthus and GRAIL, is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Dianthus Therapeutics and GRAIL, LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GRAIL, LLC and Dianthus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dianthus Therapeutics are associated (or correlated) with GRAIL, LLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GRAIL, LLC has no effect on the direction of Dianthus Therapeutics i.e., Dianthus Therapeutics and GRAIL, LLC go up and down completely randomly.

Pair Corralation between Dianthus Therapeutics and GRAIL, LLC

Given the investment horizon of 90 days Dianthus Therapeutics is expected to under-perform the GRAIL, LLC. But the stock apears to be less risky and, when comparing its historical volatility, Dianthus Therapeutics is 2.17 times less risky than GRAIL, LLC. The stock trades about -0.04 of its potential returns per unit of risk. The GRAIL, LLC is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  1,873  in GRAIL, LLC on December 2, 2024 and sell it today you would earn a total of  1,983  from holding GRAIL, LLC or generate 105.87% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Dianthus Therapeutics  vs.  GRAIL, LLC

Dianthus Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Dianthus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.

GRAIL, LLC

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in GRAIL, LLC are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite quite weak basic indicators, GRAIL, LLC disclosed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Dianthus Therapeutics and GRAIL, LLC

The main advantage of trading using opposite Dianthus Therapeutics and GRAIL, LLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dianthus Therapeutics position performs unexpectedly, GRAIL, LLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GRAIL, LLC will offset losses from the drop in GRAIL, LLC's long position.

The idea behind Dianthus Therapeutics and GRAIL, LLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.